The Lancet Neurology in conversation with
A podcast by The Lancet Group - Thursdays
187 Episodes
-
Giuseppe Citerio on frailty and TBI
Published: 1/19/2022 -
Alberto Costa on memantine in adolescents and young adults with Down syndrome
Published: 12/20/2021 -
Olivier Rascol on amantadine for patients with movement disorders
Published: 11/17/2021 -
Antonio Uccelli on stems cells for MS
Published: 10/20/2021 -
Priya Palta on blood pressure control and cognitive decline
Published: 9/15/2021 -
Adam Boxer on tau biomarkers
Published: 8/18/2021 -
Irene Cortese on the difficulties of designing clinical trials
Published: 7/21/2021 -
Doug Turnbull on mitochondrial diseases in adults
Published: 6/16/2021 -
Geert Jan Biessels on predicting post-stroke cognitive impairment
Published: 5/19/2021 -
Henk-Jan Westeneng on the causal effects of pre-symptomatic lifestyle on ALS
Published: 4/21/2021 -
Anne MacGregor on menstrual migraine
Published: 3/17/2021 -
Peter Rothwell on asymptomatic carotid stenosis and stroke
Published: 2/17/2021 -
Spinal cord injury and degenerative cervical myelopathy
Published: 1/20/2021 -
Genetic risk factors for sCJD
Published: 12/22/2020 -
Prednisone in short-term prevention of cluster headache
Published: 11/24/2020 -
PET imaging of inflammation in neurological and psychiatric disorders
Published: 10/21/2020 -
Neurological associations of COVID-19
Published: 9/4/2020 -
Advances in understanding of Rett syndrome
Published: 7/31/2020 -
Management of Parkinson's disease
Published: 6/17/2020 -
Optimal time to treat Huntington's Disease
Published: 5/26/2020
Editors at The Lancet Neurology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from sleep habits to amyloid biomarkers in Alzheimer’s, the diagnosis and classification of optic neuritis to treatment of Creutzfeldt-Jakob disease, and more.